Castle Biosciences CSTL Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$12.83M-153% | -$24.16M-232% | -$12.24M-301% | -$9.47M-205% | -$5.07M+83.5% | ||
| $14.94M-64.8% | $40.77M+155% | $42.76M+218% | $42.49M+225% | $42.42M+232% | ||
| $44.49M-8.9% | $45.89M-8.8% | $45.93M-9.4% | $46.85M-7.6% | $48.82M-3.1% | ||
| $48.25M-26.5% | $64.35M-0.8% | $61.78M— | $62.49M— | $65.67M— | ||
| $43.74M+82.9% | $36.02M+27.2% | $36.4M+48.3% | $27.95M+35.5% | $23.91M+23.0% | ||
| —— | —— | —— | —— | —— | ||
| -$10.54M— | -$7.06M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $4.52M-89.2% | $28.33M-22.5% | $25.38M— | $34.54M— | $41.75M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Castle Biosciences generate?
- Castle Biosciences (CSTL) generated $48.3M in operating cash flow over the trailing twelve months.
- What is Castle Biosciences's free cash flow?
- After $43.7M of capital expenditures, Castle Biosciences's free cash flow was $4.5M over the trailing twelve months, down 89.2% year over year.
- Where does Castle Biosciences's cash flow data come from?
- Every line is extracted from Castle Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
